Antimicrobial treatment of occult bacteremia: a multicenter cooperative study

Pediatr Infect Dis J. 1993 Jun;12(6):466-73. doi: 10.1097/00006454-199306000-00003.

Abstract

This prospective multicenter study was conducted to define more clearly clinical and laboratory criteria that predict a strong probability of occult bacteremia and to evaluate the effect of empiric broad spectrum antimicrobial treatment of these children. Children 3 to 36 months old with fever > or = 40 degrees C (104 degrees F) or, > or = 39.5 degrees C (103 degrees F) with white blood cells (WBC) > or = 15 x 10(9)/liter, and no focus of infection had blood cultures obtained and were randomized to treatment with oral amoxicillin/potassium clavulanate or intramuscular ceftriaxone. Sixty of 519 (11.6%) study patients had positive blood cultures: Streptococcus pneumoniae, 51; Haemophilus influenzae b, 6; Neisseria meningitidis, 2; and Group B Streptococcus, 1. Subgroups of high risk were identified as fever > or = 39.5 degrees C and WBC > or = 15 x 10(9)/liter, 55 of 331 or 16.6% positive with increasing incidence of positive culture with increasing increments of degrees of leukocytosis to WBC > or = 30 x 10(9)/liter where 9 of 21 or 42.9% were positive. Subgroups of significantly lower risk were identified as fever > or = 39.5 degrees C and WBC < 15 x 10(9)/liter, 5 of 182 or 2.7% positive and those with WBC < 10 x 10(9)/liter, 0 of 99 or 0.0% positive. Children with positive cultures who received ceftriaxone were nearly all afebrile after 24 hours whereas a significant number who received amoxicillin/potassium clavulanate remained febrile. In the 459 culture-negative children more amoxicillin/potassium clavulanate-treated children developed diarrhea and had less improvement in clinical scores after 24 hours than ceftriaxone-treated children.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Amoxicillin / administration & dosage
  • Amoxicillin / therapeutic use*
  • Amoxicillin-Potassium Clavulanate Combination
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / therapeutic use*
  • Child, Preschool
  • Clavulanic Acids / administration & dosage
  • Clavulanic Acids / therapeutic use*
  • Drug Therapy, Combination / administration & dosage
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Fever
  • Follow-Up Studies
  • Haemophilus Infections / drug therapy
  • Humans
  • Infant
  • Injections, Intramuscular
  • Leukocytosis
  • Male
  • Meningococcal Infections / drug therapy
  • Multivariate Analysis
  • Pneumococcal Infections / drug therapy
  • Prospective Studies
  • Regression Analysis
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Clavulanic Acids
  • Amoxicillin-Potassium Clavulanate Combination
  • Ceftriaxone
  • Amoxicillin